APA (7th ed.) Citation

Zeuzem, S., Barnard, R., Howe, J., Ogert, R., Ralston, R., Boparai, N., . . . Jacobson, I. (2011). 9 BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS (RAVS) ARE OBSERVED MORE FREQUENTLY IN HCV (GT1)-INFECTED PATIENTS WITH POOR RESPONSE TO PEGINTERFERON ALFA-2B/RIBAVIRIN. Journal of Hepatology, 54, S4. https://doi.org/10.1016/S0168-8278(11)60011-1

Chicago Style (17th ed.) Citation

Zeuzem, S., et al. "9 BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS (RAVS) ARE OBSERVED MORE FREQUENTLY IN HCV (GT1)-INFECTED PATIENTS WITH POOR RESPONSE TO PEGINTERFERON ALFA-2B/RIBAVIRIN." Journal of Hepatology 54 (2011): S4. https://doi.org/10.1016/S0168-8278(11)60011-1.

MLA (9th ed.) Citation

Zeuzem, S., et al. "9 BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS (RAVS) ARE OBSERVED MORE FREQUENTLY IN HCV (GT1)-INFECTED PATIENTS WITH POOR RESPONSE TO PEGINTERFERON ALFA-2B/RIBAVIRIN." Journal of Hepatology, vol. 54, 2011, p. S4, https://doi.org/10.1016/S0168-8278(11)60011-1.